"Lean" Body Type Could Be a Predictor of Alzheimer's Risk, Study



[ad_1]

Posted: Thursday, July 05, 2018 @ 20:36


If you are considered sarcopenic obese, or "lean", beware. According to a new report, your body type could be related to dementia.

>> Read more recent trends

Researchers at Florida Atlantic University's Global Center for Brain Health recently conducted a study to determine the link between obesity, muscle tissue and dementia. precursor sign of Alzheimer's disease.

To do this, they used data from a series of studies on aging and memory that focused on 353 elderly people on average 69 years old. The researchers evaluated individuals who were "lean", the combination of low muscle mass and strength in the context of high body fat, and their performance on different tests of cognition.

After analyzing the results, they found that "lean" subjects had the lowest performance on overall cognition, followed by those who had only sarcopenia alone and those who were obese only.

Researchers Discovered Obesity and Sarcopenia When they are evaluated independently, they are associated with a lower executive function, such as working memory, mental flexibility, self-control, and self-control. # 39; s orientation. "Understanding the mechanisms by which this syndrome can affect cognition is important because it can inform efforts to prevent cognitive decline in life later by targeting at-risk groups with an imbalance between lean body mass and body fat." , said lead author James E. Galvin in a statement. "They can benefit from programs dealing with the loss of cognitive function by maintaining and improving strength and preventing obesity." [19659007] Scientists do not know why obesity is associated with cognitive dysfunction.However, they believe that sedentary behavior, inflammation and vascular damage could be factors.On the other hand, the Sarcopenia has already been linked to impairments in the abilities related to conflict resolution and selective attention.

They concluded that lean fat is a problem important public health and encourages physicians to pay attention to patients. who could be at risk.

"Sarcopenia, alone or in the presence of obesity, can be used in clinical practice to estimate the potential risk of cognitive impairment," coauthor Magdalena I. Tolea. "The evaluation of the grip strength by dynamometry can be easily administered within the time limits of a visit to the clinic, and the body mass index is usually collected as part of annual visits of well-being. "

[ad_2]
Source link